Mirtazapine Tablet, Film Coated
Product Images NDC 70954-830

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 70954-830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container-1 (Container 1)

This text provides information about Mirtazapine tablets, USP, containing 7.5 mg of mirtazapine per tablet. The usual dosage information can be found in the package insert. The medication guide should be dispensed to each patient with 30 tablets per prescription. The storage instructions recommend keeping the tablets between 20°C to 25°C and protecting them from light and moisture. The medication should be dispensed in a light-resistant container and kept out of reach of children. The product is distributed by ANI Pharmaceuticals, Inc. in Baudette, MN.*

FDA Label Image

Label-2 (Label 2)

This is a description of Mirtazapine tablets, USP. Each tablet contains 15 mg of mirtazapine, USP. The usual dosage information can be found in the package insert. It is recommended to store the tablets at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F) and protect from light and moisture. The medication needs to be dispensed in a tight, light-resistant container and kept out of reach of children. It is distributed by ANI Pharmaceuticals, Inc. Make sure to provide each patient with the accompanying Medication Guide.*

FDA Label Image

Label-3 (Label 3)

This text provides information about a medication with the NDC 70954-888-10 containing 30 mg mirtazapine, USP, and gives guidelines on the usual dosage as listed in the package insert. The storage instructions recommend storing at 20°C to 25°C with excursions allowed to 15°C to 30°C, protecting from light and moisture. It also advises dispensing in a tight, light-resistant container as described in the USP. The medication should be kept out of the reach of children, and a Medication Guide should be dispensed to each patient. The manufacturer is ANI Pharmaceuticals, Inc., and the product consists of 30 tablets.*

FDA Label Image

Label-4 (Label 4)

This is a description of Mirtazapine tablets containing 45 mg of the active ingredient. It provides instructions for storage at a temperature range of 20°C to 25°C, with permissible excursions. The medication should be protected from light and moisture and dispensed in a tight, light-resistant container. It is intended for adult use, and each tablet should be accompanied by a Medication Guide. The prescription is for 30 tablets, and the usual dosage information can be found in the package insert. The medicine is distributed by ANI Pharmaceuticals, Inc., with details on storage, dosage, and distribution provided on the label.*

FDA Label Image

Structure (Structure)

FDA Label Image

Table (Table)

This text provides a list of potential warning signs related to mental health that individuals should be aware of. These signs include attempts to commit suicide, acting aggressively, experiencing new or worsening depression, panic attacks, increased irritability, extreme changes in activity levels or talking (mania), acting on dangerous impulses, thoughts of suicide, increased anxiety, feeling restless or agitated, sleep disturbances, and other unusual changes in behavior or mood. Recognizing and addressing these symptoms promptly is crucial for supporting mental well-being.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.